FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel derivatives of quinoline that can be used as ligands of neuropeptide Y (NPY) receptors and being first of all as neuropeptide Y (NPY) antagonists. Invention describes compounds of the formula (I): wherein R1 means -O-R4 or -NR5R6; R2 means hydrogen atom, alkyl, alkoxy-group or halogen atom; R3 means alkyl or halogen atom; R means hydrogen atom, alkyl, phenyl, phenyl substituted with 1-3 substitutes chosen independently of one another from group comprising alkyl, cyano-group, trifluoromethyl, alkoxy-group, halogen atom, pyrrolidinylcarbonyl and nitro-group, alkoxyalkyl or heterocyclyl that means saturated or aromatic 4-10-membered heterocycle comprising one heteroatom chosen from nitrogen, oxygen atoms; R5 and R6 are chosen independently of one another from group comprising hydrogen atom, alkyl or phenyl; or R5 and R6 in common with nitrogen atom (N) to which they are added form 5-10-membered heterocyclic ring comprising nitrogen atom optionally; A1 means 5-7-membered saturated heterocyclic ring comprising nitrogen atom added to quinoline ring and the second nitrogen atom optionally and wherein ring is substituted optionally with 1-3 substitutes chosen independently of one another from group comprising alkyl, alkoxy-, hydroxy-group, hydroxyalkyl, alkoxyalkyl, tetrahydropyranyloxyalkyl and cycloalkylalkoxy-group; A2 means -CH2- or -C(O)- wherein alkyl individually or in combination means alkyl group with a direct chain that comprises 1-8 carbon atoms; and their pharmaceutically acceptable salts and alkyl esters. Also, invention describes methods for synthesis of compounds of the formula (I) and pharmaceutical composition based on thereof.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
21 cl, 1 tbl, 117 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF QUINOLINE AS NPY ANTAGONISTS | 2003 |
|
RU2298002C2 |
DERIVATIVES OF QUINAZOLINE | 2003 |
|
RU2296757C2 |
DERIVATIVES OF DIHYDROBENZODIAZEPIN-2-ONE FOR TREATMENT OF NEUROLOGICAL DISORDERS | 2003 |
|
RU2315764C2 |
(3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
PHENYLGLYCINE DERIVATIVES | 1999 |
|
RU2198871C1 |
PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
DERIVATIVES OF NICOTINE- OR ISONICOTINE-BENZOTHIAZOLE AND MEDICINAL AGENT | 2002 |
|
RU2294933C2 |
METHOD FOR IMPROVEMENT OF STABILITY OF SWEET TASTE INTENSIFIERS AND COMPOSITION CONTAINING STABILISED SWEET TASTE INTENSIFIER | 2011 |
|
RU2576451C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS I mGluR2 ANTAGONISTS | 2002 |
|
RU2270197C2 |
DERIVATIVES OF (3-METHYLPYRROLIDIN-3-YL)-METHYL PYRIDINYL ETHER AND THEIR USE AS ANTAGONISTS OF RECEPTOR NK-3 | 2011 |
|
RU2625798C2 |
Authors
Dates
2007-06-10—Published
2002-09-20—Filed